ITMR

COM:ITAMAR-MEDICAL

Itamar Medical

  • Stock

Last Close

30.87

01/01 00:00

Volume Today

1.02M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
average inventory
1.26M
-
1.51M
19.43%
1.68M
11.69%
2.02M
20.21%
2.25M
11.15%
2.80M
24.54%
5.26M
88.05%
average payables
893.50K
-
1.07M
19.64%
1.19M
11.27%
1.29M
8.70%
1.39M
7.46%
1.77M
27.56%
3.22M
81.83%
average receivables
2.95M
-
3.85M
30.56%
4.55M
18.09%
5.40M
18.73%
6.33M
17.05%
7.98M
26.21%
9.37M
17.38%
book value per share
-3.20
-
-0.82
74.41%
2.65
423.95%
0.60
77.41%
0.16
73.88%
0.76
385.69%
1.50
97.83%
3.11
106.96%
capex per share
-0.02
-
-0.03
52.59%
-0.09
153.62%
-0.05
40.85%
-0.03
35.33%
-0.04
4.73%
-0.05
40.10%
-0.16
226.43%
capex to depreciation
-0.26
-
-0.62
139.79%
-1.53
145.62%
-1.05
31.54%
-0.58
44.53%
-0.64
10.83%
-0.43
34.05%
-1.23
188.60%
capex to operating cash flow
0.02
-
0.04
69.93%
0.07
75.88%
0.04
34.42%
0.05
11.86%
0.08
66.74%
0.25
-
capex to revenue
-0.01
-
-0.01
58.08%
-0.03
171.27%
-0.02
26.21%
-0.01
42.05%
-0.01
10.37%
-0.02
36.55%
-0.05
210.55%
cash per share
4.12
-
3.15
23.70%
5.59
77.63%
2.99
46.55%
1.23
58.87%
0.74
40.17%
1.36
85.45%
2.86
110.15%
days of inventory on hand
93.44
-
108.94
16.59%
131.04
20.29%
130.78
0.20%
164.91
26.10%
142.47
13.61%
175.76
23.37%
212.19
20.73%
days payables outstanding
60.35
-
82.39
36.52%
87.50
6.20%
97.06
10.93%
92.09
5.12%
96.70
5.01%
105.99
9.60%
130.86
23.47%
days sales outstanding
63.41
-
79.90
26.00%
89.50
12.02%
98.59
10.16%
102.72
4.19%
102.97
0.24%
106.74
3.66%
85.37
20.02%
debt to assets
1.62
-
1.19
26.09%
0.61
48.71%
0.85
39.20%
0.94
9.70%
0.64
31.96%
0.50
21.71%
0.33
34.07%
debt to equity
-2.62
-
-6.15
134.35%
1.58
125.70%
5.78
265.89%
14.45
149.92%
1.75
87.89%
0.99
43.27%
0.49
50.73%
dividend yield
earnings yield
-0.24
-
-0.05
80.08%
-0.03
37.45%
-0.14
368.29%
-0.05
63.41%
-0.02
67.38%
-0.04
125.55%
-0.04
7.75%
enterprise value
62.94M
-
75.09M
19.31%
58.61M
21.94%
99.45M
69.68%
108.70M
9.30%
104.17M
4.16%
127.59M
22.48%
271.34M
112.67%
enterprise value over ebitda
-8.14
-
-239.89
2,846.09%
24.00
110.00%
-10.78
144.90%
-388.20
3,502.13%
-315.67
18.68%
-34.86
88.96%
-32.18
7.69%
ev to operating cash flow
-13.22
-
-13.80
4.38%
-6.81
50.65%
-9.36
37.44%
-17.58
87.94%
-26.83
52.58%
-30.77
-
ev to sales
4.72
-
4.58
2.90%
3.49
23.89%
5.39
54.65%
5.25
2.64%
4.31
17.98%
4.08
5.22%
6.61
62.00%
free cash flow per share
-1.06
-
-0.97
8.86%
-1.43
48.12%
-1.27
11.70%
-0.74
41.91%
-0.48
35.27%
-0.80
-
free cash flow yield
-0.09
-
-0.08
8.86%
-0.12
48.12%
-0.11
11.70%
-0.06
41.91%
-0.04
35.27%
-0.04
-
graham net net
-3.77
-
-1.30
65.45%
2.01
253.93%
0.05
97.37%
-0.41
873.36%
0.11
127.97%
0.64
463.04%
2.12
230.93%
graham number
14.25
-
3.22
77.42%
4.58
42.34%
4.71
2.85%
1.46
69.09%
1.83
25.86%
4.01
118.76%
7.44
85.50%
income quality
0.37
-
1.66
350.89%
3.83
130.55%
0.74
80.74%
1.17
58.01%
2.25
92.58%
0.81
-
intangibles to total assets
0.01
-
0.01
41.51%
0.01
22.85%
0.01
11.74%
0.01
80.07%
0.02
24.46%
0.50
2,975.22%
0.02
96.76%
interest coverage
-1.08
-
-1.44
33.27%
-1.30
9.18%
-2.17
66.57%
-1.32
39.18%
-3.93
197.56%
-17.23
338.40%
-18.41
6.81%
interest debt per share
5.41
-
2.93
45.84%
2.99
1.92%
2.56
14.28%
1.72
32.89%
0.66
61.69%
0.56
15.40%
0.47
15.04%
inventory turnover
3.91
-
3.35
14.23%
2.79
16.87%
2.79
0.20%
2.21
20.70%
2.56
15.75%
2.08
18.94%
1.72
17.17%
invested capital
-1.36
-
-3.05
124.22%
0.88
128.80%
3.39
286.03%
7.77
128.82%
0.75
90.38%
0.35
52.72%
0.14
60.66%
market cap
54.95M
-
69.94M
27.29%
76.72M
9.70%
105.02M
36.88%
105.64M
0.60%
105.64M
0%
142.71M
35.08%
275.02M
92.72%
net current asset value
-15.78M
-
-5.77M
63.46%
14.82M
357.02%
2.86M
80.72%
-777K
127.20%
4.57M
688.03%
11.72M
156.58%
36.37M
210.25%
net debt to ebitda
-1.03
-
-16.44
1,490.78%
-7.42
54.89%
0.60
108.13%
-10.90
1,907.40%
4.46
140.88%
4.13
7.35%
0.44
89.43%
net income per share
-2.82
-
-0.56
80.08%
-0.35
37.45%
-1.65
368.29%
-0.60
63.41%
-0.20
67.38%
-0.48
141.91%
-0.79
66.27%
operating cash flow per share
-1.04
-
-0.93
10.20%
-1.35
44.20%
-1.21
9.80%
-0.70
42.19%
-0.44
37.19%
-0.64
-
payables turnover
6.05
-
4.43
26.75%
4.17
5.84%
3.76
9.85%
3.96
5.40%
3.77
4.77%
3.44
8.76%
2.79
19.01%
receivables turnover
5.76
-
4.57
20.63%
4.08
10.73%
3.70
9.23%
3.55
4.02%
3.54
0.24%
3.42
3.53%
4.28
25.02%
research and ddevelopement to revenue
0.14
-
0.12
13.28%
0.17
36.85%
0.17
3.83%
0.20
14.05%
0.15
24.60%
0.14
3.85%
0.15
1.15%
return on tangible assets
-0.55
-
-0.13
75.60%
-0.05
61.54%
-0.41
689.33%
-0.25
38.15%
-0.10
62.15%
-0.32
230.89%
-0.17
45.17%
revenue per share
2.91
-
2.81
3.47%
2.63
6.50%
2.11
19.84%
2.35
11.60%
2.75
16.85%
2.82
2.60%
2.96
5.11%
roe
0.88
-
0.69
22.18%
-0.13
119.31%
-2.75
1,973.15%
-3.85
40.08%
-0.26
93.28%
-0.32
22.28%
-0.25
19.66%
roic
6.33
-
-0.81
112.75%
0.25
130.82%
0.81
225.19%
-1.26
255.39%
-0.85
31.98%
-5.19
507.53%
-0.26
95.01%
sales general and administrative to revenue
0.37
-
0.28
22.75%
0.26
9.53%
0.29
13.75%
0.25
12.35%
0.22
14.92%
0.20
6.29%
0.21
1.94%
shareholders equity per share
-3.20
-
-0.82
74.41%
2.65
423.95%
0.60
77.41%
0.16
73.88%
0.76
385.69%
1.50
97.83%
3.11
106.96%
stock based compensation to revenue
0.01
-
0.09
739.49%
0.03
71.71%
0.10
278.21%
0.06
35.10%
0.04
32.47%
0.04
-
tangible asset value
-14.98M
-
-4.98M
66.79%
16.67M
434.97%
4.98M
70.10%
1.10M
77.93%
6.39M
480.91%
118K
98.15%
42.03M
35,522.88%
tangible book value per share
-3.27
-
-0.85
73.91%
2.61
405.35%
0.57
78.15%
0.12
78.06%
0.73
480.91%
0.01
98.53%
3.04
28,423.48%
working capital
11.23M
-
18.86M
67.89%
36.99M
96.16%
18.84M
49.06%
3.36M
82.19%
6.22M
85.40%
14.95M
140.29%
39.45M
163.84%

All numbers in (except ratios and percentages)